Open Access
CC BY 4.0 · Eur J Dent
DOI: 10.1055/s-0046-1816079
Original Article

Head and Neck Radiotherapy Short-Term Oral Complications: Effect on Oral Health-Related Quality of Life at Dharmais Cancer Hospital

Authors

  • Mohamad Zulfikar Idris

    1   Oral Medicine Residency Program, Faculty of Dentistry, Universitas Indonesia, Jakarta, Indonesia
  • Yuniardini Septorini Wimardhani

    2   Oral Medicine Department, Faculty of Dentistry, Universitas Indonesia, Jakarta, Indonesia
  • Widya Apsari

    3   Oral Medicine Division, Department of Dentistry, Dharmais Cancer Hospital, Jakarta, Indonesia
  • Masita Mandasari

    2   Oral Medicine Department, Faculty of Dentistry, Universitas Indonesia, Jakarta, Indonesia

Fundings This research is funded by the Directorate of Research and Development, Universitas Indonesia, under a Hibah Publikasi Terindeks Internasional (PUTI) Grant 2024 (number: NKB-99/UN2.RST/HKP.05.00/2024).

Abstract

Objective

To describe the effect of short-term oral complications of head and neck cancer (HNC) radiotherapy on patients' quality of life (QoL). Radiotherapy is one of the most common HNC therapy modality, either as the primary therapy or in combination with others. However, high-dose radiotherapy can cause both short- and long-term oral complications. Short-term oral complications of radiotherapy include oral mucositis, hyposalivation, dysphagia, and sensory disturbances which can affect the patients' ability to speak, chewing, and swallowing, leading to weight loss and a decline in QoL, thus delaying the therapy process.

Materials and Methods

This is a cross-sectional study at the Dharmais Cancer Hospital in March to April 2024, with a total of 53 participants. The data collected included participants' sociodemographic profiles, oral conditions, and oral health-related quality of life (OHRQoL) measured with the Oral Health Impact Profile 14 (OHIP-14) questionnaire, which was adapted to Indonesian language.

Statistical Analysis

Kendall and Spearman tests with a significance level of 5% were used to analyze the correlations between variables for bivariate analysis.

Results

Study participants consisted of 32 males (60.4%) and 21 females (39.6%), with the majority (22 participants, 41.5%) aged 46 to 55 years old. Nasopharyngeal cancer was reported to be the most prevalent HNC diagnosis in this study at 69.8%. All study participants (100%) experienced xerostomia and had clinical oral dryness as their short-term radiotherapy-related oral complications. The distribution of OHIP-14 scores showed that most of the participants (73.6%) had moderate OHRQoL. Xerostomia and dysphagia were shown to have statistically significant influence on OHIP-14 score (Spearman test, p < 0.05).

Conclusion

The majority of HNC patients treated with radiotherapy in Dharmais Cancer Hospital have moderate QoL. Dysphagia and xerostomia were reported as the primary drivers of reduced QoL in our study, indicating potential key targets for preventive and management strategies in HNC radiotherapy patients.



Publication History

Article published online:
12 February 2026

© 2026. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Ferlay J, Colombet M, Soerjomataram I. et al. Cancer statistics for the year 2020: an overview. Int J Cancer 2021; 149: 778-789
  • 2 Brook I. Early side effects of radiation treatment for head and neck cancer. Cancer Radiother 2021; 25 (05) 507-513
  • 3 Buchanan GD, Gamieldien MY, Tredoux S, Uys A, Swanepoel NJ. Complications of head and neck radiotherapy: a dental perspective. Arch Oncol 2019; 25: 19-21
  • 4 Waring E, Mawardi H, Woo SB. et al. Evaluation of a community-based dental screening program prior to radiotherapy for head and neck cancer: a single-center experience. Support Care Cancer 2019; 27 (09) 3331-3336
  • 5 Steen-Olsen EB, Stormoen DR, Kristensen CA, Vogelius IR, Holländer-Mieritz C, Pappot H. Patient-reported outcome during radiotherapy for head and neck cancer: the use of different PRO questionnaires. Eur Arch Otorhinolaryngol 2022; 279 (08) 4199-4206
  • 6 Kouri M, Vadalouca A, Kouloulias V. et al. Oral complications of head and neck cancer therapy. Forum Clin Oncol 2021; 12: 52-66
  • 7 Kufta K, Forman M, Swisher-McClure S, Sollecito TP, Panchal N. Pre-radiation dental considerations and management for head and neck cancer patients. Oral Oncol 2018; 76: 42-51
  • 8 Liang L, Liu Z, Zhu H. et al. Efficacy and safety of thalidomide in preventing oral mucositis in patients with nasopharyngeal carcinoma undergoing concurrent chemoradiotherapy: a multicenter, open-label, randomized controlled trial. Cancer 2022; 128 (07) 1467-1474
  • 9 Silva M, Melo A, Barbosa K, Pereira J, Alves P, Gomes D. Evaluation of oral health status and quality of life of head and neck cancer patients after radiation therapy. Stomatol Glas Srb 2014; 61: 14-20
  • 10 Faul F, Erdfelder E, Buchner A, Lang AG. Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods 2009; 41 (04) 1149-1160
  • 11 Lalla RV, Sonis ST, Peterson DE. Management of oral mucositis in patients who have cancer. Dent Clin North Am 2008; 52 (01) 61-77 , viii
  • 12 Wimardhani YS, Rahmayanti F, Maharani DA, Mayanti W, Thomson WM. The validity and reliability of the Indonesian version of the Summated Xerostomia Inventory. Gerodontology 2021; 38 (01) 82-86
  • 13 Hijjaw O, Alawneh M, Ojjoh K. et al. Correlation between Xerostomia index, Clinical Oral Dryness Scale, and ESSPRI with different hyposalivation tests. Open Access Rheumatol 2019; 11: 11-18
  • 14 Navazesh M, Kumar SKS. University of Southern California School of Dentistry. Measuring salivary flow: challenges and opportunities. J Am Dent Assoc 2008; 139: 35S-40S
  • 15 Ratnawidya W, Rahmayanti F, Soegiyanto AI, Mandasari M, Wardhany II. Indonesian short version of the oral health impact profile (OHIP-14). J Int Med Dent 2018; 11: 1065-1071
  • 16 Sen S, Priyadarshini SR, Sahoo PK, Dutta A, Singh AK, Kumar U. Palliative oral care in patients undergoing radiotherapy: Integrated review. J Family Med Prim Care 2020; 9 (10) 5127-5131
  • 17 Barsouk A, Aluru JS, Rawla P, Saginala K, Barsouk A. Epidemiology, risk factors, and prevention of head and neck squamous cell carcinoma. Med Sci (Basel) 2023; 11 (02) 42
  • 18 Badola A, Mehta P, Mehra S, Sood S. Epidemiology and survival analysis of head and neck cancer: Results from comprehensive care center in North India. Oral Oncol Rep 2023; 6: 100022
  • 19 To'Bungan N, Hamidatul A'liyah S, Wijayanti N, Fachiroh J. Epidemiologi, stadium, dan derajat diferensiasi kanker kepala dan leher. Biogenesis: Jurnal Ilmiah Biologi 2015; 3: 47-52
  • 20 Park JO, Nam IC, Kim CS. et al. Sex differences in the prevalence of head and neck cancers: A 10-year follow-up study of 10 million healthy people. Cancers (Basel) 2022; 14 (10) 2521
  • 21 Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Head and neck squamous cell carcinoma. Nat Rev Dis Primers 2020; 6 (01) 92
  • 22 Ferlay J, Ervik M, Lam F. et al. Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Accessed December 14, 2025 at: https://gco.iarc.who.int/today
  • 23 Gormley M, Creaney G, Schache A, Ingarfield K, Conway DI. Reviewing the epidemiology of head and neck cancer: definitions, trends and risk factors. Br Dent J 2022; 233 (09) 780-786
  • 24 Lalango F, Kabagenyi F, Seguya A, Byaruhanga R, Otiti J. A descriptive study on diagnostic timelines, and factors influencing delayed diagnosis among adult head and neck cancer patients at Uganda Cancer Institute. World J Surg Oncol 2024; 22 (01) 130
  • 25 Fekadu A, Rick TJ, Tigeneh W, Kantelhardt EJ, Incrocci L, Jemal A. Clinicopathology and treatment patterns of head and neck cancers in Ethiopia. JCO Glob Oncol 2022; 8: e2200073
  • 26 Bhandari S, Soni BW, Ghoshal S. Impact of non-compliance with oral care on radiation caries in head and neck cancer survivors. Support Care Cancer 2021; 29 (08) 4783-4790
  • 27 Warnakulasuriya S, Greenspan JS. eds. Textbook of oral cancer: prevention, diagnosis and management. Cham, Switzerland.: Springer; 2020: 253-283
  • 28 Grégoire V, Langendijk JA, Nuyts S. Advances in radiotherapy for head and neck cancer. J Clin Oncol 2015; 33 (29) 3277-3284
  • 29 Algouneh A, Schneider K, Huang K, Hussein A, Pan M. Comparison of volumetric modulated arc therapy (VMAT) and conventional intensity-modulated radiotherapy (IMRT) for locally advanced head and neck squamous cell carcinoma: a retrospective cohort study. Cureus 2024; 16 (05) e61022
  • 30 Bertl K, Savvidis P, Kukla EB. et al. Including dental professionals in the multidisciplinary treatment team of head and neck cancer patients improves long-term oral health status. Clin Oral Investig 2022; 26 (03) 2937-2948
  • 31 Spijkervet FKL, Schuurhuis JM, Stokman MA, Witjes MJH, Vissink A. Should oral foci of infection be removed before the onset of radiotherapy or chemotherapy?. Oral Dis 2021; 27 (01) 7-13
  • 32 PDQ Supportive and Palliative Care Editorial Board. Oral complications of cancer therapies (PDQ®): health professional version. 2024 Feb 16. In: PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002 . Accessed December 14, 2025 at: https://pubmed.ncbi.nlm.nih.gov/26389320/
  • 33 Sohn HO, Park EY, Jung YS, Lee JY, Kim EK. Effects of the professional oral care management program on patients with head and neck cancer after radiotherapy: A 12-month follow-up. J Dent Sci 2021; 16 (01) 453-459
  • 34 Nibu KI, Hayashi R, Asakage T. et al. Japanese clinical practice guideline for head and neck cancer. Auris Nasus Larynx 2017; 44 (04) 375-380
  • 35 Tolentino Ede S, Centurion BS, Ferreira LHC, Souza AP, Damante JH, Rubira-Bullen IRF. Oral adverse effects of head and neck radiotherapy: literature review and suggestion of a clinical oral care guideline for irradiated patients. J Appl Oral Sci 2011; 19 (05) 448-454
  • 36 Sivam A, Garg A, Sillifant P. Unforeseen outcomes post treatment for radiation induced trismus: a case report. Medicines (Basel) 2022; 9 (05) 31
  • 37 Song JS, Vallance P, Biron V, Jeffery CC. Epidemiological trends of head and neck Cancer survivors in Alberta: towards improved understanding of the burden of disease. J Otolaryngol Head Neck Surg 2020; 49 (01) 46
  • 38 Palmieri M, Sarmento DJS, Falcão AP. et al. Frequency and evolution of acute oral complications in patients undergoing radiochemotherapy: treatment for head and neck squamous cell carcinoma. Ear Nose Throat J 2021; 100 (Suppl. 05) 449S-455S
  • 39 Abou-Bakr A, Hassanein FEA, William H, Ibrahim SS. Prevalence of late xerostomia and hyposalivation with associated risk factors in survivors of head and neck cancer after radiotherapy: a multi-centric cross-sectional study. Radiat Oncol 2025; 20 (01) 162
  • 40 Mathlin J, Courtier N, Hopkinson J. Taste changes during radiotherapy for head and neck cancer. Radiography (Lond) 2023; 29 (04) 746-751
  • 41 Kaul R, Angrish P, Arora K, Jain P. Dental complications of head and neck radiotherapy and their management: a review. Univ Res J Dent 2015; 5 (03) 165-170
  • 42 Asif M, Moore A, Yarom N, Popovtzer A. The effect of radiotherapy on taste sensation in head and neck cancer patients - a prospective study. Radiat Oncol 2020; 15 (01) 144
  • 43 Hunter M, Kellett J, Toohey K, D'Cunha NM, Isbel S, Naumovski N. Toxicities caused by head and neck cancer treatments and their influence on the development of malnutrition: review of the literature. Eur J Investig Health Psychol Educ 2020; 10 (04) 935-949
  • 44 Nutting C, Finneran L, Roe J. et al; DARS Trialist Group. Dysphagia-optimised intensity-modulated radiotherapy versus standard intensity-modulated radiotherapy in patients with head and neck cancer (DARS): a phase 3, multicentre, randomised, controlled trial. Lancet Oncol 2023; 24 (08) 868-880
  • 45 Alexidis P, Kolias P, Mentesidou V. et al. Investigating predictive factors of dysphagia and treatment prolongation in patients with oral cavity or oropharyngeal cancer receiving radiation therapy concurrently with chemotherapy. Curr Oncol 2023; 30 (05) 5168-5178
  • 46 Sroussi HY, Epstein JB, Bensadoun RJ. et al. Common oral complications of head and neck cancer radiation therapy: mucositis, infections, saliva change, fibrosis, sensory dysfunctions, dental caries, periodontal disease, and osteoradionecrosis. Cancer Med 2017; 6 (12) 2918-2931
  • 47 Ali YM, El-Kady MS, Ali HS, Abdelatief DAA, Abdelslam SN. Effect of educational guidelines on reducing chemotherapy induced oral mucositis based on patients' needs assessment. Int J Res Pharm Sci 2020; 11: 2570-2574
  • 48 Tian X, Xu L, Liu X. et al. Impact of honey on radiotherapy-induced oral mucositis in patients with head and neck cancer: a systematic review and meta-analysis. Ann Palliat Med 2020; 9 (04) 1431-1441
  • 49 Ayuningtyas NF, Basalamah FF, Brahmanikanya GL. et al. Correlation between salivary oxidative stress biomarkers and clinical severity of radiation-induced oral mucositis in head and neck cancer patients. Eur J Dent 2025; 19 (04) 1115-1119
  • 50 Maria OM, Eliopoulos N, Muanza T. Radiation-induced oral mucositis. Front Oncol 2017; 7: 89
  • 51 Afrin KT, Ahmad S. 3D conformal, IMRT and VMAT for the treatment of head and neck cancer: a brief literature review. J Radiother Pract 2022; 21: 259-262
  • 52 Hassanein FEA, Mikhail C, Elkot S, Abou-Bakr A. L-arginine vs. L-glutamine oral suspensions for radiation-induced oral mucositis: a triple-blind randomized trial. J Cancer Res Clin Oncol 2025; 151 (07) 198
  • 53 Prakash V, Singh RK, Saurabh K. et al. Spectrum of chemo-radiotherapy induced fungal infection in head and neck cancer patients at tertiary care centre of Eastern India. Oral Oncol Rep 2023; 6: 100039
  • 54 Tesic M, Cankovic M, Jevtic M, Stevanovic D. Validation of the oral health impact profile - 14 in patients with head and neck cancer. Med Oral Patol Oral Cir Bucal 2020; 25 (06) e739-e744
  • 55 Suarantari NM, Winata A. Gambaran skor OHIP-14 pasien kanker kepala dan leher yang mendapatkan radioterapi dan kemoterapi di RSUP Sanglah. E-Jurnal Medika 2019; 8: 1-11
  • 56 Bhalla A, NA, pal Bhalla A, Singh SB, Gupta P, Bhalla S. Oral health related quality of life (OHRQOL) amongst head and neck cancer patients undergoing chemotherapy and radiotherapy at Sawi Mansingh Hospital Jaipur, India. Scholars Acad J Biosci 2015; 3: 3-12